Search research articles
Contact Us
Filters
Showing results (301-310 of 366) with videos related to
Page
of 37
Sort By:
Antimicrobial Agents and Chemotherapy
|
January 1, 1986
Preliminary trial of recombinant fibroblast interferon in chronic hepatitis B virus infection
M Eisenberg, S Rosno, G Garcia, et al.
Hepatology (Baltimore, Md.)
|
March 1, 1985
Preliminary observation of hepatitis B-associated membranous glomerulonephritis treated with leukocyte interferon
G Garcia, G Scullard, C Smith, et al.
The New England Journal of Medicine
|
May 4, 1978
Human leukocyte interferon for the treatment of herpes zoster in patients with cancer
T C Merigan, K H Rand, R B Pollard, et al.
The New England Journal of Medicine
|
September 2, 1976
Effect of human leukocyte interferon on hepatitis B virus infection in patients with chronic active hepatitis
H B Greenberg, R B Pollard, L I Lutwick, et al.
JAMA
|
April 23, 1982
Vidarabine monophosphate and human leukocyte interferon in chronic hepatitis B infection
C I Smith, L W Kitchen, G H Scullard, et al.
Journal of Acquired Immune Deficiency Syndromes
|
August 1, 1994
HIV-1 syncytium-inducing phenotype, virus burden, codon 215 reverse transcriptase mutation and CD4 cell decline in zidovudine-treated patients
M J Kozal, R W Shafer, M A Winters, et al.
Annals of Internal Medicine
|
August 15, 1994
Didanosine resistance in HIV-infected patients switched from zidovudine to didanosine monotherapy
M J Kozal, K Kroodsma, M A Winters, et al.
The Journal of Infectious Diseases
|
June 1, 1989
Evaluation of the antiviral effect of rifabutin in AIDS-related complex
J Torseth, G Bhatia, S Harkonen, et al.
Journal of Virology
|
October 24, 2000
Genotypic, phenotypic, and modeling studies of a deletion in the beta3-beta4 region of the human immunodeficiency virus type 1 reverse transcriptase gene that is associated with resistance to nucleoside reverse transcriptase inhibitors
M A Winters, K L Coolley, P Cheng, et al.
Antimicrobial Agents and Chemotherapy
|
August 1, 1989
Pharmacokinetics of rifabutin
M H Skinner, M Hsieh, J Torseth, et al.
Page
of 37
Search research articles
Search
Showing results (301-310 of 366) with videos related to
Sort By:
Page
of 37
Antimicrobial Agents and Chemotherapy
|
January 1, 1986
Preliminary trial of recombinant fibroblast interferon in chronic hepatitis B virus infection
M Eisenberg, S Rosno, G Garcia, et al.
Hepatology (Baltimore, Md.)
|
March 1, 1985
Preliminary observation of hepatitis B-associated membranous glomerulonephritis treated with leukocyte interferon
G Garcia, G Scullard, C Smith, et al.
The New England Journal of Medicine
|
May 4, 1978
Human leukocyte interferon for the treatment of herpes zoster in patients with cancer
T C Merigan, K H Rand, R B Pollard, et al.
The New England Journal of Medicine
|
September 2, 1976
Effect of human leukocyte interferon on hepatitis B virus infection in patients with chronic active hepatitis
H B Greenberg, R B Pollard, L I Lutwick, et al.
JAMA
|
April 23, 1982
Vidarabine monophosphate and human leukocyte interferon in chronic hepatitis B infection
C I Smith, L W Kitchen, G H Scullard, et al.
Journal of Acquired Immune Deficiency Syndromes
|
August 1, 1994
HIV-1 syncytium-inducing phenotype, virus burden, codon 215 reverse transcriptase mutation and CD4 cell decline in zidovudine-treated patients
M J Kozal, R W Shafer, M A Winters, et al.
Annals of Internal Medicine
|
August 15, 1994
Didanosine resistance in HIV-infected patients switched from zidovudine to didanosine monotherapy
M J Kozal, K Kroodsma, M A Winters, et al.
The Journal of Infectious Diseases
|
June 1, 1989
Evaluation of the antiviral effect of rifabutin in AIDS-related complex
J Torseth, G Bhatia, S Harkonen, et al.
Journal of Virology
|
October 24, 2000
Genotypic, phenotypic, and modeling studies of a deletion in the beta3-beta4 region of the human immunodeficiency virus type 1 reverse transcriptase gene that is associated with resistance to nucleoside reverse transcriptase inhibitors
M A Winters, K L Coolley, P Cheng, et al.
Antimicrobial Agents and Chemotherapy
|
August 1, 1989
Pharmacokinetics of rifabutin
M H Skinner, M Hsieh, J Torseth, et al.
Page
of 37